This guidance will fully update the following:
In late March, we decided to cancel all committee meetings and not publish any draft or final guidelines until further notice (except for guidance that is therapeutically critical or focused on COVID-19-related issues – see the link in the yellow banner at the top of the page). We are continuing with work where we can, however the consultation for this guideline will be delayed. We will provide further information on the revised timeline as soon as possible.
 
Status Schedule affected by COVID-19
Developed As CG

Project Team

Developer National Guideline Alliance

Email enquiries

Timeline

Key events during the development of the guidance:

Date Update
14 May 2020 Schedule affected by COVID-19. In late March, we decided to cancel all committee meetings and not publish any draft or final guidelines until further notice (except for guidance that is therapeutically critical or focused on COVID-19-related issues – see the link in the yellow banner at the top of the page). We are continuing with work where we can, however the consultation for this guideline will be delayed. We will provide further information on the revised timeline as soon as possible.
05 August 2019 Declaration of interests
05 August 2019 Committee list updated
01 February 2018 Committee meeting
01 February 2018 Stakeholder list updated
24 January 2018 Scope published
18 October 2017 - 15 November 2017 Draft scope consultation
18 October 2017 - 15 November 2017 Committee member recruitment
18 October 2017 Recruitment for GC members began on 18/10/2017 and will close on 15/11/2017. You can find more information here: https://www.nice.org.uk/Get-Involved/join-a-committee
21 September 2017 Scoping workshop
25 May 2017 - 08 June 2017 Committee chair recruitment
25 May 2017 - 08 June 2017 Topic expert committee member recruitment

For further information on the guideline development process, please read how we develop NICE guidelines